Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELI domain containing 3B pseudogene 8 (PRELID3BP8) is a processed pseudogene found in the human genome, annotated by HGNC (HGNC:49070) and Ensembl (ENSG00000270741). Pseudogenes are nonfunctional genomic DNA sequences that are homologous to normal genes but typically lack the ability to encode a functional protein, often due to frameshifts, premature stop codons, or other disabling mutations. Processed pseudogenes arise from the reverse transcription and reintegration of an mRNA transcript into the genome. PRELID3BP8 shares sequence similarity with the functional PRELI domain containing 3B gene but lacks evidence for transcription, translation, or biological function in humans. Key points: - PRELID3BP8 is a human processed pseudogene with no evidence of protein-coding or therapeutic relevance. - It is not considered a drug target or involved in any recognized disease mechanism. - There are no known drugs, biomarkers, or safety issues associated with this pseudogene. - Its annotation as a pseudogene renders it scientifically incorrect to refer to it as a protein, receptor, enzyme, or drug target in pharmacological contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELI domain containing 3B pseudogene 8 (PRELID3BP8).